Get the Stockscreener App
7.08
0.85%
0.06
Pre-market:
7.11
0.03
+0.42%
Teladoc Health Inc stock is traded at $7.08, with a volume of 5.09M.
It is up +0.85% in the last 24 hours and down -5.85% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$7.02
Open:
$6.95
24h Volume:
5.09M
Relative Volume:
0.99
Market Cap:
$1.30B
Revenue:
$2.59B
Net Income/Loss:
$-981.73M
P/E Ratio:
-1.227
EPS:
-5.77
Net Cash Flow:
$206.95M
1W Performance:
-4.32%
1M Performance:
-5.85%
6M Performance:
-29.69%
1Y Performance:
-29.97%
1-Day Range:
$6.8845
$7.26
1-Week Range:
$6.85
$7.58
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
2 MANHATTANVILLE ROAD, PURCHASE, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.08 | 1.30B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
281.89 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
70.11 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
58.51 | 11.00B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
100.01 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.33 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Strong Option Activity Observed in Teladoc (TDOC) | TDOC Stock News - GuruFocus
Digital Therapeutics Market: Opportunities in Mental Health - openPR.com
Teladoc (TDOC) Rises Higher Than Market: Key Facts - Yahoo Finance
mHealth Ecosystem Market Hits New High | Major Giants- Teladoc Health, Cisco Systems, Google - openPR.com
Teladoc (TDOC) Sees Surge in Call Options Activity | TDOC Stock News - GuruFocus
Emerging Trends in Direct-to-Consumer Medical Services Market - openPR.com
Telehealth and Telemedicine Market Generated Opportunities, - openPR.com
AI-powered Telemedicine Market Generated Opportunities, - openPR.com
Upcoming Opportunities in Virtual Medical Appointment Market: - openPR.com
M&A to play ‘important role’ at Teladoc: CEO - Healthcare Dive
(TDOC) Long Term Investment Analysis - news.stocktradersdaily.com
Robust Growth in Future-Focused Patient Engagement Solutions - openPR.com
Teladoc at Goldman Sachs Conference: Strategic Focus on Growth - Investing.com Australia
Transcript : Teladoc Health, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 09 - marketscreener.com
Incredible Growth of Remote Healthcare Support Solutions - openPR.com
Urgent Care Apps Market Set to Experience Telemedicine - openPR.com
Telehealth Services Market Is Booming So Rapidly 2025-2032 - openPR.com
DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know - Yahoo Finance
Telepsychiatry Market Future Business Opportunities - openPR.com
Lucet to Acquire Home Care Company Emcara Health - Dealbreaker
HIMS' Buyouts Fuel International Expansion & Digital Health Innovation - TradingView
Telepsychiatry Market Set to Witness Significant Growth by 2033 - openPR.com
Telestroke Services Market Is Booming So Rapidly 2025-2032 - openPR.com
Teladoc Health to Participate in Upcoming Investor Conference | - GuruFocus
Teladoc Health to Participate in Upcoming Investor Conference | TDOC Stock News - GuruFocus
Teladoc Health to Participate in Upcoming Investor Conference - GlobeNewswire
Virtual Care Leader Teladoc Takes Center Stage at Goldman Sachs Healthcare Conference - Stock Titan
Smart Telehealth Market Is Booming Worldwide 2025-2032 | Teladoc Health, Inc., American Well Corporation - openPR.com
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | TDOC Stock News - GuruFocus
Doximity Rides on Telehealth Demand: Will This Drive Sales Further? - sharewise
Business Opportunities in Asia-Pacific's USD 215.5 Billion Telemedicine Market, 2033 - GlobeNewswire
Telehealth Solutions Market 2025 | Growth Trends, Virtual Care, - openPR.com
Province ends virtual doctor pilot in Sussex hospital - Telegraph-Journal
Teladoc Health Executives Sell Shares - TradingView
Teladoc Health Announces Employee Inducement Awards under NYSE R - GuruFocus
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - The Manila Times
Teladoc Awards New Hires Massive 80,000-Share Stock Package Under NYSE Rule 303A.08 - Stock Titan
Ovatient Launches Virtual-First Care Offering at MUSC Health - Healthcare Innovation
Digital Healthcare Market Set to Witness Technology-Driven - openPR.com
Which Telehealth Stock Should You Be Targeting? - Schaeffer's Investment Research
Current and Future Analysis of Cost-Effective Medical Services - openPR.com
How the (TDOC) price action is used to our Advantage - news.stocktradersdaily.com
Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report? - sharewise
Teladoc (TDOC) Sees Surge in Bullish Options Activity | TDOC Sto - GuruFocus
Empowering Growth: Virtual Patient Interaction Solutions - openPR.com
AI Diagnostics Telehealth Platforms Market Generated - openPR.com
Teladoc Health (TDOC) Target Price Lowered by B of A Securities | TDOC Stock News - GuruFocus
Upcoming Opportunities in Patient Communication Solutions - openPR.com
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
4.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):